02.01.2015 Views

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 4.2.2 continued<br />

Author<br />

Year<br />

Reference<br />

Country<br />

Study<br />

design<br />

Population<br />

characteristics<br />

Intervention<br />

Method<br />

Number indi<strong>vid</strong>uals<br />

Control<br />

Number<br />

indi<strong>vid</strong>uals<br />

Results<br />

Withdrawal<br />

Drop outs<br />

Study quality<br />

and relevance<br />

Comments<br />

Giercksky<br />

1982<br />

[23]<br />

Norway<br />

RCT<br />

Pts undergoing elective<br />

colorectal surgery.<br />

Female/male: 107/127.<br />

Mean age 62 years.<br />

n=240<br />

I: Tinidazole 800 mg and<br />

doxycycline 200 mg 1 h<br />

before operation and<br />

in total of 5 days (n=116)<br />

C: Tinidazole<br />

160 mg + doxycycline<br />

400 mg 2 h<br />

before operation.<br />

Single dose (n=118)<br />

Wound infection<br />

I: 6 pts<br />

C: 0 pts<br />

Intraabdominal/pelvic<br />

abscess<br />

I: 5 pts<br />

C: 4 pts<br />

6 pts were<br />

excluded<br />

Moderate<br />

Not blinded.<br />

Randomisation<br />

not described<br />

Sepsis<br />

I: 2 pts<br />

C: 0 pts<br />

Ishida<br />

2001<br />

[20]<br />

Japan<br />

RCT<br />

Pts undergoing colorectal<br />

surgery<br />

Intervention:<br />

Female/male: 29/42.<br />

Mean age 65 years<br />

Control:<br />

Female/male: 25/47.<br />

Mean age 62 years<br />

n=146<br />

I: Mechanical bowel preparation<br />

+ 1 g cefotiam at 0,<br />

end of operation, 1 g x 2<br />

for additional 2 days (n=71)<br />

C: Mechanical<br />

bowel preparation<br />

+ 1 g cefotiam at 0,<br />

end of operation,<br />

1 g x 2 for additional<br />

2 days +<br />

oral kanamycin<br />

2 g/day + erythromycin<br />

1.6 g/day<br />

di<strong>vid</strong>ed in 4 doses<br />

daily for 2 days<br />

before surgery<br />

(n=72)<br />

SSI including incisional<br />

infections and organspace<br />

infections<br />

I: 23.9%<br />

C: 11.1% p=0.04<br />

Distant infections<br />

I: 8.5%<br />

C: 5.6% p=0.36<br />

MRSA infection<br />

I: 5.6%<br />

C: 11.1% p=0.19<br />

Remote infections<br />

caused by MRSA<br />

I: 2.8%<br />

C: 9.7% p=0.086<br />

3 pts were<br />

excluded<br />

Moderate<br />

SSI less in the<br />

group of pts<br />

receiving oral<br />

antibiotics.<br />

However, MRSA<br />

distant infections<br />

were higher (sign)<br />

in this group. The<br />

trial goes against<br />

all other studies<br />

due to 3 days of<br />

iv antibiotics was<br />

used. In metaanalysis<br />

[1]<br />

The table continues on the next page<br />

164 antibiotikaprofylax <strong>vid</strong> <strong>kirurgiska</strong> <strong>ingrepp</strong> KAPITEL 4 • den systematiska litteraturöversikten<br />

165

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!